
GSK partners with China's Hengrui Pharma in $12 B deal for 12 innovative medicines
GSK partners with China's Hengrui Pharma in $12 B deal for 12 innovative medicines July 29, 2025 | Tuesday | News To complement GSK’s extensive Respiratory, Immunology & Inflammation (RI&I) and Oncology pipeline image credit- shutterstock GSK …